Dr Steven Bradshaw in the Press

Dr Steven Bradshaw has been mentioned throughout the world press. Here’s where Steven has been mentioned:

Global Healthcare Environment Strategy Firm Appoints British Medical Research Expert as its European Director - Yahoo Finance

Dr Steven Bradshaw , a medical research expert, has been appointed as the European Director of a leading global healthcare environment strategy consulting firm, Market Access Solutions (MKTXS).

 

MKTXS Appoints Dr Steven Bradshaw as Director - Pharmafile

Global healthcare strategy firm MKTXS has appointed British medical research expert Dr Steven Bradshaw as its new European director.

 

Medical Research Expert to Mentor Researchers in Developing Countries - LabBulletin

Dr Steven Bradshaw, a former Ophthalmologist and medical research expert, has signed up to be become a mentor at AuthorAID to support developing countries researchers in publishing their work to the global audience.

 

Medical Research Expert to Mentor Researchers in Developing Countries - BioPharmaDive

Dr Steven Bradshaw, a former Ophthalmologist and medical research expert, has signed up to be become a mentor at AuthorAID to support developing countries researchers in publishing their work to the global audience.

 

Wet AMD Drug Changed by Italy Government - Hospital Pharmacy Europe

Dr Steven Bradshaw, a drug policy expert and former ophthalmologist, is disappointed at the news of the Italian government’s decision to change the wet age-related macular degeneration (AMD) treatment drug.

 

Drug Policy Expert Calls for “nip in the bud” for AMD Therapy Drug Substitute - The Pharma Letter

Steven Bradshaw, a UK-based drug policy expert and former ophthalmologist, is disappointed at the news.

 

Concern Over Replacement AMD Drug - Pan European Networks

A drug policy expert and former ophthalmologist has said he is disappointed at the news of the Italian Government’s decision to substitute the wet age-related macular degeneration (AMD) treatment drug Lucentis with Roche’s Avastin.

 

Nip in the Bud for Drug Substitute - Scientist Live

Former ophthalmologist and international drug policy expert argues the Italian government should reconsider the decision to substitute AMD drug for the safety of patients and out of respect to other EU member nations.

 

Leading Drugs Industry Acquisitions Expert Says AstraZeneca Takeover Could be Good News for NHS - 4-Traders

Dr Steven Bradshaw has urged critics to see benefits in the deal.

 

Leading Drugs Industry Acquisitions Expert Says AstraZeneca Takeover Could be Good News for NHS. Dr Steven Bradshaw Urges Critics to See Benefits – To Stakeholders, Healthcare Providers and Patients - Pharmiweb

Dr Steven Bradshaw, who advises major pharmaceutical companies on drug pricing, market access and portfolio evaluations, says the takeover could be a good thing for Britain and the NHS.

 

Japanese Stem Cell Research Raises Wider Discussion on Medical Research Ethics - Pharmiweb

Dr Steven Bradshaw consultant at Emedits Global believes the recent story concerning possible research misconduct in Japan raises wider discussions on research ethics and transparency.

 

Stem Cell Fraud Raises Ethics Debate - OptometryToday

A former medical editor at Nature Publishing Group has called for wider discussion on research ethics, transparency and the potential implications of research fraud.

 

Dr Steven Bradshaw blog logo